Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Should atopic dermatitis patients starting JAK inhibitors take prophylactic acyclovir?
By
- AMS
posted
Oct 13, 2021 08:32 AM
0
Recommend
Volume 32, Issue 7
, November 2021, Page 669-672
.
0 comments
0 views
Permalink
Related Content
Concomitant atopic dermatitis and psoriasis – a retrospective review
- AMS
Added Dec 18, 2019
Blog Entry
Punctal stenosis associated with dupilumab therapy for atopic dermatitis
- AMS
Added Jan 08, 2020
Blog Entry
Comparing the effects of proactive treatment with tacrolimus ointment and mometasone furoate on the epidermal barrier structure and ceramide levels of patients with atopic dermatitis
- AMS
Added Jan 04, 2020
Blog Entry
Dermatologist attitudes toward ciclosporin use in atopic dermatitis
- AMS
Added Feb 10, 2020
Blog Entry
Glycerol 85% efficacy on atopic skin and its microbiome: a randomized controlled trial with clinical and bacteriological evaluation
- AMS
Added Jan 06, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic